A detailed history of California Public Employees Retirement System transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 228,859 shares of HALO stock, worth $10.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
228,859
Previous 241,568 5.26%
Holding current value
$10.9 Million
Previous $12.6 Million 3.52%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$51.3 - $64.42 $651,971 - $818,713
-12,709 Reduced 5.26%
228,859 $13.1 Million
Q2 2024

Aug 14, 2024

BUY
$37.81 - $52.4 $317,414 - $439,898
8,395 Added 3.6%
241,568 $12.6 Million
Q1 2024

Apr 30, 2024

SELL
$33.68 - $41.95 $235,928 - $293,859
-7,005 Reduced 2.92%
233,173 $9.49 Million
Q4 2023

Feb 01, 2024

SELL
$33.32 - $42.1 $335,632 - $424,073
-10,073 Reduced 4.03%
240,178 $8.88 Million
Q3 2023

Nov 02, 2023

BUY
$36.46 - $44.03 $82,800 - $99,992
2,271 Added 0.92%
250,251 $9.56 Million
Q2 2023

Aug 09, 2023

SELL
$30.28 - $38.74 $3.7 Million - $4.74 Million
-122,233 Reduced 33.02%
247,980 $8.94 Million
Q1 2023

May 12, 2023

SELL
$32.86 - $55.7 $312,860 - $530,319
-9,521 Reduced 2.51%
370,213 $14.1 Million
Q4 2022

Feb 08, 2023

BUY
$40.06 - $59.44 $2.77 Million - $4.11 Million
69,077 Added 22.24%
379,734 $21.6 Million
Q3 2022

Nov 09, 2022

BUY
$38.53 - $51.78 $1.79 Million - $2.41 Million
46,521 Added 17.61%
310,657 $12.3 Million
Q2 2022

Aug 10, 2022

SELL
$37.35 - $48.3 $807,992 - $1.04 Million
-21,633 Reduced 7.57%
264,136 $11.6 Million
Q1 2022

May 04, 2022

SELL
$31.97 - $41.06 $762,004 - $978,665
-23,835 Reduced 7.7%
285,769 $11.4 Million
Q4 2021

Feb 10, 2022

SELL
$31.82 - $40.75 $179,178 - $229,463
-5,631 Reduced 1.79%
309,604 $12.4 Million
Q3 2021

Nov 10, 2021

BUY
$38.47 - $46.42 $10,617 - $12,811
276 Added 0.09%
315,235 $12.8 Million
Q2 2021

Aug 13, 2021

SELL
$38.84 - $51.31 $724,832 - $957,547
-18,662 Reduced 5.59%
314,959 $14.3 Million
Q1 2021

May 14, 2021

SELL
$39.51 - $51.45 $260,845 - $339,672
-6,602 Reduced 1.94%
333,621 $13.9 Million
Q4 2020

Feb 02, 2021

BUY
$25.81 - $43.62 $715,066 - $1.21 Million
27,705 Added 8.87%
340,223 $14.5 Million
Q3 2020

Nov 05, 2020

BUY
$25.74 - $29.63 $235,134 - $270,670
9,135 Added 3.01%
312,518 $8.21 Million
Q2 2020

Aug 12, 2020

BUY
$16.25 - $26.81 $42,396 - $69,947
2,609 Added 0.87%
303,383 $8.13 Million
Q1 2020

May 12, 2020

SELL
$13.9 - $21.83 $3.31 Million - $5.2 Million
-238,428 Reduced 44.22%
300,774 $5.41 Million
Q4 2019

Jan 27, 2020

BUY
$14.93 - $19.53 $3.62 Million - $4.73 Million
242,426 Added 81.69%
539,202 $9.56 Million
Q3 2019

Oct 31, 2019

BUY
$15.2 - $17.69 $2.03 Million - $2.36 Million
133,400 Added 81.65%
296,776 $4.6 Million
Q2 2019

Aug 15, 2019

BUY
$14.75 - $17.26 $70,416 - $82,399
4,774 Added 3.01%
163,376 $2.81 Million
Q1 2019

May 03, 2019

SELL
$13.94 - $17.58 $29,274 - $36,918
-2,100 Reduced 1.31%
158,602 $2.55 Million
Q4 2018

Feb 08, 2019

SELL
$13.33 - $18.66 $260,988 - $365,344
-19,579 Reduced 10.86%
160,702 $2.35 Million
Q3 2018

Nov 13, 2018

SELL
$16.68 - $18.41 $145,466 - $160,553
-8,721 Reduced 4.61%
180,281 $3.28 Million
Q2 2018

Aug 15, 2018

SELL
$16.87 - $20.3 $107,934 - $129,879
-6,398 Reduced 3.27%
189,002 $3.19 Million
Q1 2018

May 11, 2018

SELL
$17.06 - $21.2 $160,364 - $199,280
-9,400 Reduced 4.59%
195,400 $3.83 Million
Q4 2017

Feb 06, 2018

BUY
$16.75 - $20.8 $118,925 - $147,680
7,100 Added 3.59%
204,800 $4.15 Million
Q3 2017

Nov 15, 2017

BUY
$11.76 - $17.4 $2.32 Million - $3.44 Million
197,700
197,700 $3.43 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.